Salicylates Group
Topics
These substances were identified for action under the Chemicals Management Plan (CMP). This screening assessment focuses on five substances referred to collectively as the Salicylates Group.
| Substance group | CAS RN | Common name | DSL name | Draft screening assessment | Risk management scope | Proposed conclusion on section 64 criteria | Follow-up activities |
|---|---|---|---|---|---|---|---|
| Salicylates Group | 69-72-7 | Salicylic acid | Benzoic acid, 2-hydroxy- | HTML | HTML | Meets one or more of the criteria | Refer to risk management scope |
| 87-22-9 | Phenethyl salicylate | Benzoic acid, 2-hydroxy-, 2-phenylethyl ester | None | Does not meet | Under consideration | ||
| 118-56-9 | Homosalate | Benzoic acid, 2-hydroxy-, 3,3,5-trimethylcyclohexyl ester | HTML | Meets one or more of the criteria | Refer to risk management scope | ||
| 68917-75-9Table 1 Footnote a | Wintergreen oil | Oils, wintergreen | |||||
| 84012-15-7Table 1 Footnote a | Betula alba extract | Birch, Betula alba, ext. | None | Does not meet | None planned at this time | ||
|
|||||||
| Date | Activity |
|---|---|
| August 29, 2026 | Publication in Canada Gazette, Part I, of a notice under section 71 of Canadian Environmental Protection Act (CEPA). |
| March 14, 2020 | Publication and start of 60-day public comment period on the Draft Screening Assessment for the Salicylates Group and the Risk Management Scope for Wintergreen Oil, Salicylic Acid and Homosalate. The related notice was published in the Canada Gazette, Part I: Vol. 154, No. 11. |
Information gathering
Section 71 CMP 2026 – Phase 1
In August 2026, a notice was published in the Canada Gazette, Part I: Vol. 160, No. 35 – August 29, 2026, under section 71 of CEPA. This notice applies to one substance included in this substance grouping (CAS RN 68917-75-9). More information is available on the information gathering with respect to certain substances under the CMP web page.